Current treatments for diabetes primarily include metformin, sulfonylureas, GLP-1 receptor agonists, DPP-4 inhibitors, and sodium-glucose cotransporter 2 (SGLT2) inhibitors. This evidence concerns the gene DPP4 and diabetes mellitus.